ENSEMBLE
DEAD

Serial Number

90811775

Owner

Element Biosciences, Inc.

Attorney

Samantha C. Markley

Filing Date

Jul 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ENSEMBLE Trademark

Serial Number: 90811775

ENSEMBLE is a trademark filed by Element Biosciences, Inc. on July 5, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Element Biosciences, Inc. (35 trademarks)

9880 Campus Point Drive, Suite 210
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

July 5, 2021

Registration Date

Not Registered

Goods & Services

Computer systems, namely, computer hardware, downloadable and recorded computer software and associated downloadable data files for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; downloadable and recorded computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; clinical diagnostic instruments for scientific use, namely, nucleic acid sequencers, imaging devices and analyzers

Medical diagnostic reagents; clinical medical diagnostic reagents; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical diagnostic purposes; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression for diagnostic medical use and for clinical medical use

Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits comprised primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression of for scientific research use, for diagnostic scientific use, and for clinical laboratory research use; clinical diagnostic reagents for laboratory use; reagent kits and reagent beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical diagnostic laboratory purposes

Clinical diagnostic instruments for medical use, namely, nucleic acid sequencers, imaging devices and analyzers

Providing reagent sample diagnostic testing services for others for scientific research purposes and scientific research related thereto; clinical diagnostic services for scientific research purposes, namely, preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings; providing online non-downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all the foregoing for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable computer software for data collection, management, and analysis of genetic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 31, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 31, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 31, 2023 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 28, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 28, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 28, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 28, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 7, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 14, 2021 NWOS
NEW APPLICATION ENTERED
Jul 8, 2021 NWAP